Page last updated: 2024-08-24

3-iodobenzylguanidine and Anemia

3-iodobenzylguanidine has been researched along with Anemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleeker, G; Caron, HN; de Kraker, J; Hoefnagel, CA; Schoot, RA; Tytgat, GA; van Eck, BL1
Cheng, SC; Hawkins, RA; Howard, JP; Huberty, JP; Kersun, LS; Maris, JM; Matthay, KK1
Ackery, D; Fielding, S; Flower, MA; Kemshead, J; Lashford, LS; Lewis, IJ1

Trials

2 trial(s) available for 3-iodobenzylguanidine and Anemia

ArticleYear
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:11

    Topics: 3-Iodobenzylguanidine; Anemia; Child; Child, Preschool; Female; Humans; Infant; Male; Nausea; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Thrombocytopenia; Vomiting

2013
A phase I/II study of 131I mIBG in chemo-resistant neuroblastoma. The United Kingdom Children's Cancer Study Group (UKCCSG).
    Progress in clinical and biological research, 1991, Volume: 366

    Topics: 3-Iodobenzylguanidine; Anemia; Antineoplastic Agents; Child, Preschool; Drug Evaluation; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neuroblastoma; Neutropenia; Radiation Injuries; Radionuclide Imaging; Thrombocytopenia

1991

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Anemia

ArticleYear
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
    Pediatric blood & cancer, 2005, Volume: 44, Issue:3

    Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Anemia; Bone Marrow; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Iodine Radioisotopes; Male; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome

2005